Search

everythinglearnresearchcommunity

for

Search:↓

Tamoxifen increases the risk of lasting hair loss after chemotherapy despite scalp cooling.

Oral dutasteride, minoxidil, and finasteride may help reduce hair loss in breast cancer survivors, but more research is needed.

Low-dose DMSO may help treat castration-resistant prostate cancer by reducing key cancer cell receptors.

Consult an oncologist before using supplements for hair loss during breast cancer treatment.

Prostaglandin E2 promotes skin cancer, but certain supplements and drugs may help reduce risk and improve treatment.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Chemotherapy worsens nutritional status in breast cancer patients, requiring targeted nutritional strategies.

Platelet-rich fibrin may help reduce nonmelanoma skin cancer cell growth.

Blocking the JAK/STAT pathway may help reduce skin sensitivity in Xeroderma pigmentosum.

Metastatic cervical cancer can cause rare, severe Cushing's syndrome with high risk of death.

Cnicus Benedictus leaf extract can kill cervical cancer cells without harming normal cells.

Patients with hematologic cancer had mild anxiety, low surgical knowledge, and the pandemic increased their anxiety.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

Physical activity, height, and smoking affect prostate cancer risk.

Enhancing immune response can improve cancer treatment effectiveness.

Anti-angiogenic drugs do not worsen COVID-19 severity in lung cancer patients.

Older ovarian cancer patients live longer and tolerate weekly chemotherapy better than three-weekly treatments.

EGFR-targeted cancer therapy can cause skin issues starting at hair follicles, leading to inflammation.

Women with female pattern hair loss tend to have lower self-esteem and body image concerns, but higher self-esteem is linked to more self-compassion.

KRT17 may be a new target for endometrial cancer treatment because it helps cancer cells move and form new blood vessels.

Hormone therapy for breast cancer often leads to sexual issues like vaginal dryness and decreased libido.

Patients with advanced breast cancer prioritize quality of life, overall survival, and progression-free survival in treatment decisions.

A group has developed therapies that show promise for treating cancer and various other conditions.

Fetal environments contain various chemicals that may disrupt hormones.

Radiation therapy in breast cancer patients changes gene expression related to DNA damage, fibroblast growth, and hair follicle development, which could help improve treatment for radiation-induced fibrosis.

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.